Conference attendance at Mello2026 Investor event

Summary by AI BETAClose X

Renalytix will present and exhibit at the Mello2026 investor event in London on 17 November 2026, with the CEO presenting at 11:50 and 16:10 and a PDF of the presentation to be posted on the company website; the release reiterates that KidneyIntelX has FDA authorization and Medicare reimbursement and is offered commercially across the United States, while disclosing no new financial guidance, revenue, profit/loss, cash or debt figures.

Disclaimer*

UK 100

Latest directors dealings